STOCKHOLDERS' EQUITY | Note 7. STOCKHOLDERS' EQUITY Series A Warrants A summary of warrant activity for the six months ended June 30, 2019 is presented below: Exercise Price Warrant Common Stock Equivalent Remaining Contractual Term Outstanding at January 1, 2019 $ 0.0001 41,642,670,772 1.50 Warrants settlement $ - - Cashless exercises for common stock $ (0.0001 ) (21,743,172 ) Black Scholes Value adjustment $ (0.0001 ) (115,104,728 ) Outstanding at June 30, 2019 $ 0.0001 41,505,822,872 1.00 Pursuant to the Series A Warrant agreement, the Black Scholes value is calculated by a third-party and utilized in calculating the warrant common stock equivalents at the point of cashless exercise. As such, the value is computed at the end of each reporting period to determine the amount of warrant common stock equivalents outstanding using the formula below: (Series A Warrants exercised * Black Scholes Value) / Closing common stock bid price as of two trading days prior. A summary of the outstanding warrant common stock equivalents at June 30, 2019 and December 31, 2018 is presented below: June 30, December 31, Warrants outstanding (A) 2.7334 2.7348 Black Scholes value (B) 1,518,481 1,522,692 Subtotal (C)=(A) x (B) 4,150,582 4,164,258 Closing bid stock price (D) $ 0.0001 $ 0.0001 Warrant common stock equivalent (C)/(D) 41,506,000,000 41,643,000,000 Stock Options The Company recognized stock-based compensation in connection with the amortization of stock options, net of recovery of stock-based charges for forfeited unvested stock options. Stock-based compensation expense is included as part of operating expenses in the accompanying consolidated statements of operations. A summary of compensation expense recognized is presented below: Three Months Ended Six Months Ended June 30, June 30, June 30, June 30, Stock-based compensation $ 83,175 $ 86,616 $ 196,254 $ 1,158,506 At June 30, 2019, the amount of unamortized stock-based compensation expense associated with unvested stock options granted to employees, directors and consultants was approximately $40,000, which will be amortized over a weighted average period of 1 year. Loss Per Share Basic loss per share is computed by dividing the net loss by the weighted average number of shares of common stock outstanding during the period. Diluted loss per share is computed using the weighted average number of shares of common stock outstanding and, if dilutive, potential shares of common stock outstanding during the period. Potential common shares consist of incremental shares of common stock issuable upon (a) the exercise of stock options (using the treasury stock method); (b) the conversion of Series A convertible preferred stock; (c) the exercise of warrants (using the if-converted method); (d) the vesting of restricted stock units; and (e) the conversion of convertible notes payable. Diluted income (loss) per share excludes the potential common shares, as their effect is antidilutive. The following table summarizes the Company's securities, in common share equivalents, that have been excluded from the calculation of dilutive loss per share as their effect would be anti-dilutive: June 30, 2019 2018 Preferred stock 201,501,142,000 - Stock options 90,012,230,680 89,568,899,200 Warrants 41,505,822,872 506,136,603,028 Total 333,019,195,552 595,705,502,228 |